Overall, our study first investigates the causal associations between plasma proteins and SCLC by integrative analysis, revealing that circulating CPB2, GSTM3 and NTNG1 decreased SCLC risk, while FAM171B increased SCLC risk. The gene discussed is CPB2; the disease is small cell lung carcinoma.